4//SEC Filing
LALANDE KEVIN M. 4
Accession 0001126234-24-000115
CIK 0001126234other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 9:31 PM ET
Size
17.7 KB
Accession
0001126234-24-000115
Insider Transaction Report
Form 4
LUMOS PHARMA, INC.(LUMO)
LALANDE KEVIN M.
Director
Transactions
- Disposition to Issuer
Common Stock
2024-12-12−1,076→ 0 total - Disposition to Issuer
Common Stock
2024-12-12−730,446→ 0 total(indirect: By Sante Health Ventures II, LP) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−3,345→ 0 totalExercise: $3.42Exp: 2033-05-09→ Common Stock (3,345 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−3,328→ 0 totalExercise: $2.35Exp: 2034-06-04→ Common Stock (3,328 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−2,910→ 0 totalExercise: $10.36Exp: 2031-05-19→ Common Stock (2,910 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−5,684→ 0 totalExercise: $7.78Exp: 2030-04-02→ Common Stock (5,684 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-12-12−3,431→ 0 totalExercise: $8.18Exp: 2032-05-04→ Common Stock (3,431 underlying)
Footnotes (4)
- [F1]Disposed of pursuant to that certain Agreement and Plan of Merger, dated October 22, 2024, by and between the Issuer, DPV Parent, Inc., DPV MergerSub, Inc. and Double Point Ventures LLC ("DPV") (the "Merger Agreement") in exchange for (i) $4.25 in cash per share (the "Cash Amount"), plus (ii) one non-transferable contingent value right ("CVR") per share.
- [F2]The reporting person is a managing director of SHV Management Services, LLC ("SHV Management"). SHV Management is the general partner of SHV Management Services, LP, which is the general partner of the partnership that directly owns the reported securities. The reporting person disclaims beneficial ownership of the securities reported except to the extent of his pecuniary interest, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all the reported securities for purposes of Section 16 or for any other purpose.
- [F3]This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option.
- [F4]Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement.
Documents
Issuer
LUMOS PHARMA, INC.
CIK 0001126234
Entity typeother
Related Parties
1- filerCIK 0001587800
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 9:31 PM ET
- Size
- 17.7 KB